EUVIMEDEUVIMED entdecken
Crossref

Inhalation powder development without carrier: How to engineer ultra-flying microparticles?

Anna Lechanteur, Eva Gresse, Luisa Orozco, Erwan Plougonven, Angélique Léonard, Nicolas Vandewalle, Geoffroy Lumay, Brigitte Evrard

European Journal of Pharmaceutics and Biopharmaceutics · 2023

DOI: 10.1016/j.ejpb.2023.08.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023. Verfasst von Anna Lechanteur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Liège 4000, Belgium. Electronic address: anna.lechanteur@uliege.b…. Hauptthemen laut MEDLINE: Respiratory Aerosols and Droplets, Budesonide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Région wallonne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Particle engineering technologies have led to the commercialization of new inhaled powders like PulmoSolTM or PulmoSphereTM. Such platforms are produced by spray drying, a well-known process popular for its versatility, thanks to wide-ranging working parameters. Whereas these powders contain a high drug-loading, we have studied a low-dose case, in optimizing the production of powders with two anti-asthmatic drugs, budesonide and formoterol. Using a Design of Experiments approach, 27 powders were produced, with varying excipient mixes (cyclodextrins, raffinose and maltodextrins), solution concentrations, and spray drying parameters in order to maximize deep lung deposition, measured through fine particle fraction (next generation impactor). Based on statistical analysis, two powders made of hydropropyl-β-cyclodextrin alone or mixed with raffinose and L-leucine were selected. Indeed, the two powders demonstrated very high fine particle fraction (>55%), considerably better than commercially available products. Deep lung deposition has been correlated to very fine particle size and lower microparticles interactions shown by laser diffraction assays at different working pressures, and particle morphometry. Moreover, the two drugs would be predicted to deposit homogeneously into the lung according to impaction studies. Uniform delivery is fundamental to control symptoms of asthma. In this study, we develop carrier-free inhalation powders promoting very efficient lung deposition and demonstrate the high impact of inter-particular interactions intensity on their aerosolization behaviour.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Aerosols and DropletsBudesonidePowdersRaffinoseAdministration, InhalationParticle SizeDry Powder InhalersAerosols

Stichwörter der Autor:innen

DOEDPIInhalationParticle engineeringSpray drying

Substanzen

PowdersRaffinoseBudesonideAerosols

Autor:innen und Institutionen

  • Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Liège 4000, Belgium. Electronic address: anna.lechanteur@uliege.be.
  • Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, Liège 4000, Belgium.
  • Group of Research and Applications in Statistical Physics, CESAM Research Unit Institute of Physics B5a, University of Liège, Liège 4000, Belgium.
  • PEPs, Laboratory of Chemical Engineering, Department of Applied Chemistry, University of Liège, Building B6a, Sart-Tilman, Liège 4000, Belgium.

Förderung

  • Région wallonne

Zitieren

APA

Lechanteur, A., Gresse, E., Orozco, L., Plougonven, E., Léonard, A., Vandewalle, N., Lumay, G., & Evrard, B. (2023). Inhalation powder development without carrier: How to engineer ultra-flying microparticles?. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2023.08.010

Vancouver

Lechanteur A, Gresse E, Orozco L, Plougonven E, Léonard A, Vandewalle N, et al. Inhalation powder development without carrier: How to engineer ultra-flying microparticles?. European Journal of Pharmaceutics and Biopharmaceutics. 2023. doi:10.1016/j.ejpb.2023.08.010

BibTeX
@article{Lechanteur2023,
  author = {Lechanteur, Anna and Gresse, Eva and Orozco, Luisa and Plougonven, Erwan and Léonard, Angélique and Vandewalle, Nicolas and Lumay, Geoffroy and Evrard, Brigitte},
  title = {Inhalation powder development without carrier: How to engineer ultra-flying microparticles?},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  doi = {10.1016/j.ejpb.2023.08.010}
}
Kostenlos starten →